Trial Management STREAM
-
CAR-T Cell Therapies: Advancements In Cancer Trials & Treatment
6/19/2023
Watch as Managing Editor of Pharmaceutical Technology Jeanne Linke Northrop talks with Tanmay Jain, Sr. Director of Trial Design Solutions within Medidata AI, about the use of CAR-T cell therapies within the oncology space.
-
What Is The Secret To Ongoing TMF Health?
8/22/2023
Delve into specific tactics clinical teams can utilize for establishing immediate and long-lasting improvements to their TMF business processes.
-
How RWD Reshapes Patient Recruitment Strategies
8/13/2025
Discover how real-world data (RWD) is transforming patient recruitment by shifting from traditional site-centered methods to a patient-first approach.
-
Do Mobile Visits Drive Faster Study Results?
2/27/2024
Discover solutions to clinical trial challenges — this on-demand webinar by PCM Trials and Clinical Leader offers insights into the role of mobile nurse visits in overcoming patient dropout and trial delays.
-
Are Your Clinical Study Meetings Building Momentum, Or Wasting Time?
9/17/2025
Transforming passive clinical trial meetings into active catalysts for success, aligning teams and accelerating timelines.
-
Illuminating IHC: From Biomarker To Clinical Trial Assay
5/2/2025
Through this presentation, Immunohistochemistry (IHC) expert equip you with the knowledge needed to effectively utilize IHC in your research and clinical practice.
-
Going From Good To Great As A TMF Champion
12/8/2023
Gain insight into regulatory nuances, best practices for documentation management, and strategies for fostering a culture of compliance within the team.
-
Digital Physical Activity Measures In Phase 3 Immunology Trials
2/25/2025
Dr. Jie Shen, Research Fellow and Director of Digital Science at AbbVie, shares lessons learned from incorporating digital measures of physical activity into Phase 3 immunology clinical trials.
-
Say It With Technology: How Alnylam Fosters A Connected Relationship With Sites
3/12/2021
Alnylam Pharmaceuticals is developing an entirely new class of medicines and delivered the world’s first and only approved RNAi therapeutics in 2018 and 2019. Learn how Alnylam earned its reputation among investigators as a sponsor of choice by standardizing studies on a collaborative portal more than 6 years ago and leveraging technology to deliver results.
-
Applying Virtual Approaches To Dermatology Trials
Explore how to integrate virtual approaches into the design and delivery of dermatology trials – to mitigate study risks and enhance patient engagement.